Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety and tolerability of AB680 in participants with gastrointestinal malignancies, including advanced pancreatic ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AB680

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Advanced Pancreatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING